Comparing the performance of the Charlson/Deyo and Elixhauser comorbidity measures across five European countries and three conditions

Abstract

The Elixhauser list contains more comorbidities, which may enable it to achieve better discrimination than the Charlson measure. Both measures achieve similar calibration, so for the purpose of ECHO we judged the Elixhauser measure to be preferable.